This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: I45 (Other conduction disorders) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Right Bundle Branch Block, Left Bundle Branch Block, Bifascicular block, Trifascicular block, intraventricular conduction disorder, Preexcitation syndrome, junctional rhythm |
| C. Adult onset | Occurs mainly in people in their 40s-70s against a background of underlying heart disease (ischemic heart disease, cardiomyopathy, hypertension, etc.); some types such as WPW syndrome are present congenitally and become symptomatic in adulthood. |
| 1. History | The concepts of bundle branch block and conduction disorders were established with the introduction of the electrocardiogram (ECG) in the late 19th to early 20th century. Einthoven's standardization of the electrocardiogram in 1906 and Lewis's description of bundle branch block in 1912 were the beginnings. |
| 2. Causes | Ischemic heart disease, cardiomyopathy, hypertensive heart disease, injury after cardiac surgery, myocarditis, and infiltrative diseases (amyloidosis, sarcoidosis) are the main causes. |
| 3. Genetics | Variants of ion channel-related genes such as SCN5A, KCNQ1, and KCNH2 are associated with congenital conduction disorders and WPW syndrome. |
| 4. General epidemiology | The prevalence of right bundle branch block is about 0.2-1.8% of the general adult population and of left bundle branch block 0.1-0.8%, and incidence increases with age and with underlying heart disease. |
| 5. Pathophysiology | Depolarization conduction is delayed or blocked at a specific site in the His-Purkinje conduction system, causing dyssynchrony of ventricular contraction, which leads to reduced cardiac function and arrhythmias. |
| 6. Symptoms | It is often asymptomatic, but dizziness, syncope, dyspnea, fatigue, and palpitations may occur; in bifascicular and trifascicular block there is a risk of progression to complete AV block. |
| 7. Signs | On ECG, QRS widening (≥120ms), characteristic waveform alterations, and secondary ST-T changes are observed. A split second heart sound (S2 split) may be heard on auscultation. |
| 8. Screening | The standard 12-lead electrocardiogram (ECG) is the primary screening test. In high-risk groups (history of syncope, underlying heart disease), exercise stress testing and Holter monitoring are added. |
| 9. Diagnosis | Confirmation and mechanism elucidation with 12-lead ECG, 24-hour Holter monitoring, echocardiography, electrophysiology study (EPS), and cardiac MRI (when infiltrative disease is suspected). |
| 10. Treatment | Asymptomatic simple bundle branch block: observation. Symptomatic or progressive conduction disorder: permanent pacemaker implantation. In LBBB with heart failure, cardiac resynchronization therapy (CRT) is standard. |
| 11. Prognosis | Isolated right bundle branch block is generally benign. Left bundle branch block increases cardiovascular mortality risk when associated with underlying heart disease. In patients receiving CRT, left ventricular function and symptoms improve markedly. |
| 12. Prevention | Active management of underlying conditions such as hypertension, diabetes, and coronary artery disease. Minimizing conduction system injury during cardiac surgery. Early detection through regular ECG checkups. |
| 13. References | Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology … and 9 other papers |
The modern understanding of cardiac conduction disorders is inseparable from the development of electrocardiographic technology in the late 19th century. In 1887, Augustus Waller first succeeded in recording the electrical activity of the heart from the body surface, and in 1901 Willem Einthoven opened a new horizon in cardiac electrophysiology by succeeding in recording the electrocardiogram using a string galvanometer. In 1906, Einthoven established the prototype of the standard 12-lead electrocardiogram and the naming system for the P wave, QRS complex, and T wave, for which he received the Nobel Prize in Physiology or Medicine in 1924.
The concept of bundle branch block was first systematized in 1912 when Thomas Lewis observed abnormally wide QRS waves on the electrocardiogram and interpreted them as conduction block in the left or right branch of the bundle of His. Subsequently, in 1913, Eppinger and Rothberger described in detail the electrocardiographic criteria for left bundle branch block (LBBB) and right bundle branch block (RBBB), and these criteria are still widely used in clinical practice today. In the 1930s, Holzmann and Scherf described WPW (Wolff-Parkinson-White) syndrome and revealed that abnormal conduction via an atrioventricular accessory pathway is associated with paroxysmal tachycardia.
The concept of fascicular block was established by Rosenbaum et al. in the 1960s, and electrocardiographic diagnostic criteria for left anterior fascicular block and left posterior fascicular block were proposed. The concepts of bifascicular block and trifascicular block were also introduced in this period, and research was conducted on the risk of progression to complete AV block. From the 1970s onward, with the development of permanent pacemakers, active treatment of symptomatic conduction disorders became possible, and in the 2000s Cardiac Resynchronization Therapy (CRT) was introduced, showing breakthrough treatment outcomes in heart failure patients with left bundle branch block.
Recently, conduction system pacing (CSP) techniques have drawn attention. His bundle pacing and left bundle branch area pacing are becoming established as next-generation treatments replacing conventional right ventricular apical pacing, owing to their advantage of making maximal use of the physiological conduction pathway to minimize ventricular dyssynchrony and preserve cardiac function. Thus, the history of other conduction disorders has continuously advanced together with the development of electrocardiographic technology, deepening electrophysiological understanding, and innovation in treatment devices.
Other conduction disorders can occur anywhere in the His-Purkinje conduction system of the heart, and their causes are broadly classified as structural heart disease, ischemic injury, inflammatory/infiltrative diseases, iatrogenic causes, and congenital causes.
Ischemic heart disease is the most common cause of conduction disorders. In acute myocardial infarction, particularly inferior wall myocardial infarction due to right coronary artery occlusion, AV block occurs due to AV nodal ischemia, and in anterior wall myocardial infarction due to left anterior descending artery occlusion, bundle branch block and complete AV block can appear. In chronic ischemic heart disease as well, conduction system fibers are progressively damaged, resulting in bundle branch block.
Cardiomyopathy is another major cause; in dilated cardiomyopathy, left bundle branch block due to fibrosis of the conduction system is commonly present. Conduction disorders can also appear in hypertrophic and restrictive cardiomyopathy. Hypertensive heart disease induces left ventricular hypertrophy, and the resulting compression and fibrosis of the conduction system lead to bundle branch block.
Infiltrative diseases include cardiac sarcoidosis, amyloidosis, and hemochromatosis, which directly invade the conduction system and cause various forms of conduction disorders. Cardiac sarcoidosis is a disease that must be differentiated especially when unexplained AV block or bundle branch block appears in young adults. Myocarditis can also cause conduction disorders in the acute phase, and AV block characteristically occurs in myocarditis due to Lyme disease.
Iatrogenic causes include conduction system injury after cardiac surgery (valve surgery, repair of congenital heart disease), left bundle branch block after transcatheter aortic valve replacement (TAVR), and injury after catheter ablation. Among drugs, antiarrhythmic agents (class I, class III), digoxin, calcium channel blockers, and beta-blockers can worsen conduction disorders. Congenital causes include the accessory pathway in WPW syndrome and inherited channelopathies (such as Brugada syndrome).
The role of genetic factors in cardiac conduction disorders has gradually been revealed over recent decades with advances in molecular biology. The genetic basis is particularly important in isolated conduction disorders, familial conduction disorders, and WPW syndrome.
The SCN5A gene encodes the cardiac sodium channel (Nav1.5), and loss-of-function variants of this gene are associated with slowed conduction velocity, Brugada syndrome, and progressive cardiac conduction disease (Lev-Lenègre disease). Lev-Lenègre disease is an inherited disease in which the His-Purkinje conduction system progressively degenerates with age, characterized by complete AV block and bundle branch block.
The KCNQ1, KCNH2 genes encode potassium channels, and their variants cause conduction abnormalities along with long QT syndrome. HCN4 gene variants are associated with sick sinus syndrome and AV conduction disorders. LMNA (lamin A/C) gene variants cause laminopathy, which produces both dilated cardiomyopathy and conduction disorders; this disease carries a high risk of sudden death and is an indication for an implantable cardioverter-defibrillator (ICD).
The familial form of WPW syndrome is associated with PRKAG2 gene variants and accompanied by cardiac glycogen storage disease. Transcription factor genes such as NKX2.5, GATA4, TBX5 play important roles in the development and maintenance of the His-Purkinje conduction system, and their variants are associated with congenital cardiac conduction disorders. When an inherited conduction disorder is suspected, panel testing based on next-generation sequencing (NGS) is recommended.
The prevalence of other conduction disorders varies greatly depending on the population studied, age, and the presence of underlying heart disease. According to large epidemiological studies, right bundle branch block (RBBB) has a prevalence of about 0.2-1.8% in the general adult population, and its incidence increases with age. It occurs about twice as frequently in men as in women. The prevalence of left bundle branch block (LBBB) is 0.1-0.8% in the general population, increasing to about 3-4% in those aged 65 and older.
According to long-term cohort studies including the Framingham Heart Study, RBBB generally has a good prognosis, but the risk of cardiovascular death increases 1.3-1.5-fold when underlying heart disease is present. LBBB itself is an independent risk factor for cardiovascular death and heart failure, and even in isolated LBBB without underlying heart disease, the risk of developing heart failure is reported to increase significantly over about 10 years of follow-up.
Regarding fascicular block, the prevalence of left anterior fascicular block (LAFB) is about 1-3% of adults, and alone it has little clinical significance. However, in bifascicular block with combined RBBB and LAFB, the risk of progression to complete AV block is reported to be about 1-2% per year. The prevalence of WPW syndrome is about 0.1-0.3% of the general population. Among conduction disorders after cardiac surgery, the incidence of new LBBB after transcatheter aortic valve replacement (TAVR) is reported to be particularly high at about 20-30%, an important complication that increases the need for conduction system pacing.
In Korea, according to studies based on Health Insurance Review & Assessment Service (HIRA) data, the prevalence of cardiac conduction disorders is continuously increasing with population aging, and they are emerging as a major component of cardiovascular disease in the elderly, together with atrial fibrillation and heart failure.
In the normal heart, the electrical impulse starts at the sinoatrial node (SA node), passes through the atrioventricular node (AV node) to the Bundle of His, and is distributed to the left and right ventricles via the left bundle branch and right bundle branch, respectively. The left bundle further divides into the left anterior and left posterior fascicles, conducting to the anterior and posterior walls of the left ventricle, respectively. When conduction is delayed or blocked anywhere in this conduction system, depolarization of the corresponding ventricle or segment is delayed or occurs via a bypass route.
In bundle branch block, the ventricle on the side of the blocked branch is depolarized via cell-to-cell conduction through the ventricular muscle from the opposite ventricle, so its depolarization is markedly delayed compared with normal. As a result, the QRS complex widens (≥120ms) and characteristic morphological changes appear. In LBBB, left ventricular depolarization is delayed, causing ventricular dyssynchrony, and if this persists it can lead to left ventricular remodeling, diastolic dysfunction, and eventually reduced systolic function. This is called "dyssynchrony-induced cardiomyopathy."
In preexcitation syndrome (WPW syndrome), an accessory pathway (such as the Kent bundle) bypassing the AV node is present, so atrial impulses reach the ventricles faster than through the AV node. As a result, a short PR interval, delta wave, and wide QRS are observed on ECG. Rapid conduction through this accessory pathway can give rise to dangerous situations such as atrioventricular reentrant tachycardia (AVRT) and degeneration of atrial fibrillation into ventricular fibrillation.
At the cellular level, the mechanisms of conduction disorders are divided into changes in ion channel function, rearrangement and dysfunction of gap junctions, and fibrosis and fatty infiltration of conduction system fibers. Reduced sodium channel (INa) density and decreased expression and redistribution of Cx43 (connexin 43) slow conduction velocity and promote the formation of reentrant circuits.
The clinical symptoms of other conduction disorders are highly variable and differ greatly depending on the type and location of the conduction disorder and the presence of underlying heart disease. Simple bundle branch block or fascicular block is most commonly asymptomatic and discovered incidentally on electrocardiography.
When symptoms are present, dizziness and syncope are the most clinically important. When syncope occurs in a patient with bifascicular or trifascicular block, progression to complete AV block must be considered. In particular, sudden loss of consciousness called a Stokes-Adams attack results from ventricular standstill due to complete AV block, and is characterized by lasting from several seconds to several minutes before spontaneous recovery.
Dyspnea and reduced exercise tolerance reflect reduced cardiac function due to ventricular dyssynchrony, especially in patients with LBBB. Even in patients without pre-existing heart failure, LBBB alone can cause left ventricular dysfunction over several years. Palpitations are mainly reported in WPW syndrome or conduction disorders with tachycardia, with a paroxysmal pattern of sudden onset and sudden termination. Chest pain can appear with concomitant myocardial ischemia, and LBBB itself is also a factor that makes the diagnosis of myocardial infarction difficult.
On physical examination, specific signs caused by the conduction disorder itself are limited, but careful auscultation and observation can provide important clues. Paradoxical splitting of S2 is a characteristic sign of LBBB: because left ventricular depolarization and contraction are delayed, aortic valve closure occurs later than pulmonary valve closure, so S2 splitting decreases on inspiration and instead increases on expiration. Conversely, in RBBB, fixed or physiological S2 splitting is observed.
In complete AV block, the atria and ventricles contract independently, producing findings of AV dissociation. The heart rate is then usually slow, under 40 beats per minute, and on examination of jugular venous pulsation, cannon A waves — large, irregular waves occurring when the atrium contracts against a closed tricuspid valve — are observed irregularly. Blood pressure and pulse pressure also fluctuate markedly depending on the degree of AV dissociation. During episodes of paroxysmal tachycardia in WPW syndrome, a rapid heart rate (150-250/min) accompanied by hypotension, cyanosis, and other findings may be observed.
When underlying heart disease associated with the conduction disorder (heart failure, cardiomyopathy) is present, signs of heart failure such as elevated jugular venous pressure, pulmonary crackles, lower extremity edema, displaced apical impulse, and enlarged cardiac borders are present.
The primary screening test for other conduction disorders is the standard 12-lead electrocardiogram (ECG). The electrocardiogram is noninvasive and low-cost and can rapidly identify most conduction disorders, including bundle branch block, fascicular block, and WPW syndrome. In asymptomatic patients, regular electrocardiography (especially in high-risk groups: age 65 and older, underlying heart disease, after cardiac surgery) is useful for early detection of conduction disorders.
When an intermittent or paroxysmal conduction disorder is suspected, 24-48-hour Holter monitoring is performed. When symptoms appear infrequently, long-term monitoring over months to years is possible using a repeated event monitor (event recorder) or an implantable loop recorder (ILR). The ILR has high diagnostic value especially in patients with unexplained syncope.
The exercise stress test is used to evaluate changes in conduction disorders during exercise (worsening or improvement) or to evaluate myocardial ischemia in conduction disorders accompanied by ischemic heart disease. When WPW syndrome is found in high-risk occupational groups (aircraft pilots, drivers) or athletes, evaluation of the conduction properties of the accessory pathway with exercise stress testing and electrophysiology study is recommended.
The standard 12-lead electrocardiogram is central to the diagnosis of conduction disorders. Diagnostic criteria for RBBB are QRS duration ≥120ms, an RSR' or rSR' pattern in V1, and a wide, slurred S wave in the lateral leads (I, V5-6). Criteria for LBBB are QRS ≥120ms, a broad notched R wave in V5-6 (notching or slurred R), and a deep S wave or QS pattern in V1-2. Left anterior fascicular block is diagnosed by QRS <120ms, left axis deviation (−45° or more leftward), and a qR pattern in aVL.
WPW syndrome is characterized by a shortened PR interval (<120ms), delta wave, and wide QRS. ECG findings vary with the location of the accessory pathway, and the exact location and electrical properties of the accessory pathway must be determined by electrophysiology study.
24-hour Holter monitoring is important for capturing arrhythmias associated with intermittent conduction disorders. Echocardiography is used to evaluate underlying causes of conduction disorders (structural heart disease, reduced cardiac function) and to quantify the degree of ventricular dyssynchrony with tissue Doppler imaging (TDI). Cardiac MRI evaluates myocardial fibrosis (late gadolinium enhancement) and is useful for differentiating infiltrative and structural causes such as sarcoidosis, amyloidosis, and ARVC.
The electrophysiology study (EPS) is essential for directly evaluating His-Purkinje conduction function (HV interval measurement), determining whether ventricular tachycardia can be induced, and identifying the properties of the accessory pathway in WPW syndrome (retrograde refractory period, conduction velocity). When the HV interval is 70ms or longer, the risk of progression to complete AV block is high, and pacemaker implantation is considered.
The treatment strategy for other conduction disorders is determined by comprehensively considering the type of conduction disorder, presence of symptoms, underlying heart disease, and risk of progression to complete AV block.
When asymptomatic simple bundle branch block (RBBB, LBBB) is found in isolation without underlying heart disease, periodic follow-up without specific treatment is the principle. However, when LBBB is found, underlying structural heart disease and left ventricular dysfunction must be evaluated.
Permanent pacemaker implantation is indicated in the following situations: (1) complete AV block with symptoms (syncope, recurrent dizziness), (2) asymptomatic complete AV block but with heart rate <40/min or episodes of asystole, (3) bifascicular or trifascicular block with HV interval ≥70ms or complete AV block induced during EPS, (4) symptomatic sinus node dysfunction. Regarding pacing site, practice is recently shifting toward preferential consideration of conduction system pacing (His bundle pacing, left bundle branch pacing).
Cardiac resynchronization therapy (CRT) is a Class I indication in heart failure patients with NYHA class II-IV, LBBB with QRS ≥150ms, and left ventricular ejection fraction (LVEF) ≤35%. CRT corrects ventricular dyssynchrony, improves cardiac function, and significantly reduces heart failure hospitalization and death. Cardiac MRI-based assessment of myocardial fibrosis and 3D echocardiography are used to predict CRT response.
For high-risk accessory pathways in WPW syndrome (pathway refractory period ≤250ms, concomitant atrial fibrillation, symptomatic tachycardia), radiofrequency catheter ablation is recommended as curative treatment. The success rate of ablation is over 95%, and the complication rate is less than 1-2%.
The prognosis of other conduction disorders differs by type and underlying heart disease. Isolated right bundle branch block generally has a good prognosis in the absence of underlying heart disease, and progression to complete AV block is rare. However, new-onset RBBB in acute pulmonary embolism or acute anterior wall myocardial infarction can be an indicator of poor prognosis.
Left bundle branch block significantly increases the risk of cardiovascular death when associated with underlying heart disease. In the Framingham Heart Study, the 10-year mortality of LBBB patients was about 3 times higher than that of controls, and the risk of developing heart failure also increases. However, in heart failure patients with LBBB treated with CRT, left ventricular function (LVEF) improves by an average of 10-15%, and heart failure hospitalization and mortality decrease significantly.
In bifascicular and trifascicular block, the annual rate of progression to complete AV block is about 1-2%. After appropriate pacemaker implantation, the risk of Stokes-Adams attacks and sudden death decreases greatly. In WPW syndrome, successful ablation of the accessory pathway by catheter ablation results in a low recurrence rate of less than 5% and an excellent prognosis. The risk of sudden death before ablation is higher when the pathway refractory period is short and atrial fibrillation coexists (about 0.15-0.4% per year).
Prevention of other conduction disorders focuses on the prevention and early treatment of the underlying heart diseases that cause them. For prevention of ischemic heart disease, cardiovascular risk factors such as hypertension, dyslipidemia, diabetes, smoking, and obesity must be actively managed. Along with drug therapy such as statins, antiplatelet agents, and renin-angiotensin inhibitors, lifestyle modification (regular exercise, smoking cessation, maintaining a healthy weight, Mediterranean diet) is important.
Early treatment of hypertensive heart disease prevents left ventricular hypertrophy and lowers the risk of conduction system fibrosis. Minimizing conduction system injury during cardiac surgery requires technical care, especially during TAVR, valve surgery, and repair of congenital heart disease. When new LBBB or a conduction disorder develops after TAVR, immediate ECG monitoring and, if necessary, pacemaker implantation should be considered.
Early diagnosis and treatment of infiltrative diseases such as cardiac sarcoidosis and amyloidosis help prevent progressive conduction disorders. In families suspected of having an inherited conduction disorder, early detection and follow-up of asymptomatic carriers through genetic testing and family ECG screening are recommended. Regular ECG checkups allow early detection of conduction disorders in high-risk groups so that preventive measures can be taken before progression to complete AV block.
Bashore TM, Bhimji SS. Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology. Cardiol Clin. 2023;41(3):299-310. DOI: 10.1016/j.ccl.2023.03.004. PMID: 37321688.
Sroubek J, Kaplan RM, Bhave PD. Bilateral Bundle Branch Block. Cardiol Clin. 2023;41(3):311-322. DOI: 10.1016/j.ccl.2023.03.005. PMID: 37321689.
Varma N, O'Donnell D, Bhargava K, et al. Cardiac resynchronization considerations in left bundle branch block. Heart Rhythm. 2022;19(10):1645-1654. DOI: 10.1016/j.hrthm.2022.05.032. PMID: 36187776.
Vijayaraman P, Ponnusamy SS, Cano Ó, et al. Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy: Results From the International LBBAP Collaborative Study Group. JACC Clin Electrophysiol. 2021;7(2):135-147. DOI: 10.1016/j.jacep.2020.08.015. PMID: 33478693.
Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. J Am Coll Cardiol. 2019;74(7):e51-e156. DOI: 10.1016/j.jacc.2018.10.044. PMID: 30412709.
Roubicek T, Nedbal P, Sklenar J, et al. Incidence of Persistent Left Bundle Branch Block After Rapid-Deployment Aortic Valve Replacement. Ann Thorac Surg. 2022;114(4):1247-1253. DOI: 10.1016/j.athoracsurg.2021.11.027. PMID: 35952857.
Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm. 2013;10(12):1932-1963. DOI: 10.1016/j.hrthm.2013.05.014. PMID: 24011539.
Aro AL, Anttonen O, Tikkanen JT, et al. Intraventricular conduction block in a general population: prevalence, incidence, and prognosis (FINRISK and Health 2000 studies). Eur Heart J. 2011;32(20):2725-2731. DOI: 10.1093/eurheartj/ehr227. PMID: 21885386.
Pérez-Riera AR, Barbosa-Barros R, de Rezende Barbosa MPC, et al. Conduction disorders in right and left bundle branches. Ann Noninvasive Electrocardiol. 2018;23(6):e12538. DOI: 10.1111/anec.12538. PMID: 29726050.
Mele D, Bertini M, Malagù M, et al. Current role of echocardiography in cardiac resynchronization therapy. Heart Fail Rev. 2021;26(5):1069-1083. DOI: 10.1007/s10741-020-09930-y. PMID: 32060791.